In March 2025, the company announced new plans to get a immediate-to-purchaser supplying of its Wegovy weight loss drug. The company founded a completely new pharmacy, identified as NovoCare, which would charge shoppers $499 monthly for usage of the drug, below 50 percent the expense of the drug as a result of other pharmaceutical distribution netw